Resultado da Busca
Há 3 dias · Mr. Icahn joined the board of directors of Bausch + Lomb Corporation, a publicly traded eye health company, in May 2022, and has served on the board of Icahn Enterprises L.P., a private entity since October 2020.
29 de mai. de 2024 · VAUGHAN, Ontario, May 29, 2024 -- ( BUSINESS WIRE )--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people...
29 de mai. de 2024 · The elected directors include Nathalie Bernier, Gary Hu, Brett Icahn, Sarah B. Kavanagh, Karen L. Ling, John A. Paulson, Russel C. Robertson, Thomas W. Ross Sr., Brenton L. Saunders, and Andrew C. von Eschenbach.
Há 6 dias · Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation.
Há 3 dias · Carl Icahn is one of Wall Street's most successful investors and has been shaking up corporate America for decades. Icahn's primary investing vehicle is publicly traded Icahn...
29 de mai. de 2024 · VAUGHAN, Ontario-- ( BUSINESS WIRE )-- Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2024 annual meeting of shareholders (the “Annual ...
29 de mai. de 2024 · April 25, 2024. Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes. LOAD MORE NEWS. Real-Time News, Market Data, and Stock Quotes for Life Science Stocks @ healthstockshub.com.
